[go: up one dir, main page]

TR199800801T2 - Treatment of traumatic brain injuries. - Google Patents

Treatment of traumatic brain injuries.

Info

Publication number
TR199800801T2
TR199800801T2 TR1998/00801T TR9800801T TR199800801T2 TR 199800801 T2 TR199800801 T2 TR 199800801T2 TR 1998/00801 T TR1998/00801 T TR 1998/00801T TR 9800801 T TR9800801 T TR 9800801T TR 199800801 T2 TR199800801 T2 TR 199800801T2
Authority
TR
Turkey
Prior art keywords
traumatic brain
treatment
brain injuries
injuries
injury
Prior art date
Application number
TR1998/00801T
Other languages
Turkish (tr)
Inventor
R. Pike Brian
Original Assignee
H. Lund-Beck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lund-Beck A/S filed Critical H. Lund-Beck A/S
Publication of TR199800801T2 publication Critical patent/TR199800801T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Formül I'in bilesigi 5-(2-etil-2H-tetrazol-5-il) -1,2,3,6-tetrahidro-1-metilpiridin travmatik beyin yaralanmasi örneklerinde anlama performansini artirir ve kolinerjik nöronlarin yaralanma hasarlarini azaltir ve travmatik beyin yaralanmalarinin tedavisinde kullanilan farmasötik ilaçlarin imal edilmesi için faydalidir.The compound of formula I 5- (2-ethyl-2H-tetrazol-5-yl) -1,2,3,6-tetrahydro-1-methylpyridine improves understanding performance in traumatic brain injury samples and reduces injury injuries of cholinergic neurons and traumatic brain It is useful for the manufacture of pharmaceutical drugs used in the treatment of injuries.

TR1998/00801T 1995-11-06 1996-11-05 Treatment of traumatic brain injuries. TR199800801T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK123295 1995-11-06

Publications (1)

Publication Number Publication Date
TR199800801T2 true TR199800801T2 (en) 1998-08-21

Family

ID=8102484

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/00801T TR199800801T2 (en) 1995-11-06 1996-11-05 Treatment of traumatic brain injuries.

Country Status (18)

Country Link
EP (1) EP0866706A1 (en)
JP (1) JPH11514654A (en)
KR (1) KR19990067353A (en)
AU (1) AU706594B2 (en)
BG (1) BG63150B1 (en)
BR (1) BR9611396A (en)
CA (1) CA2234824A1 (en)
CZ (1) CZ287441B6 (en)
EA (1) EA000531B1 (en)
HU (1) HUP9901051A2 (en)
IS (1) IS4726A (en)
NO (1) NO982036L (en)
NZ (1) NZ321546A (en)
PL (1) PL326490A1 (en)
SK (1) SK58198A3 (en)
TR (1) TR199800801T2 (en)
WO (1) WO1997017074A1 (en)
ZA (1) ZA969320B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR013096A1 (en) * 1997-07-01 2000-12-13 Lundbeck & Co As H SALE OF ADDITION OF MALEIC ACID OF 5- (2-ETIL-2-H-TETRAZOL-5-IL) -1-METHYL-1,2,3,6-TETRAHIDROPIRIDINA, PHARMACEUTICAL COMPOSITION THAT CONTAINS IT, ITS USE IN THERAPY AND METHOD OF PREPARATION OF THE SAME.
RU2266737C1 (en) * 2004-04-12 2005-12-27 Тихоокеанский Институт Биоорганической Химии Дальневосточного Отделения Россиской Академии Наук Method and preparation for treating the cases of hemorrhagic stroke
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
US5328925A (en) * 1989-02-22 1994-07-12 Novo Nordisk A/S Piperidine compounds and their use
IE922270A1 (en) * 1991-07-26 1993-01-27 Akzo Nv Pyrazole derivatives
US5330994A (en) * 1992-03-24 1994-07-19 Warner-Lambert Company Tetrahydropyridine isoxazoline derivatives

Also Published As

Publication number Publication date
ZA969320B (en) 1997-05-30
PL326490A1 (en) 1998-09-28
NZ321546A (en) 2000-12-22
AU706594B2 (en) 1999-06-17
EP0866706A1 (en) 1998-09-30
EA000531B1 (en) 1999-10-28
BG63150B1 (en) 2001-05-31
BG102480A (en) 1999-01-29
EA199800434A1 (en) 1998-10-29
CZ138998A3 (en) 1998-10-14
NO982036D0 (en) 1998-05-05
IS4726A (en) 1998-04-27
NO982036L (en) 1998-06-25
KR19990067353A (en) 1999-08-16
CZ287441B6 (en) 2000-11-15
JPH11514654A (en) 1999-12-14
CA2234824A1 (en) 1997-05-15
HUP9901051A2 (en) 2000-03-28
MX9803432A (en) 1998-09-30
WO1997017074A1 (en) 1997-05-15
AU7490096A (en) 1997-05-29
BR9611396A (en) 1999-07-13
SK58198A3 (en) 1998-10-07

Similar Documents

Publication Publication Date Title
NL300140I1 (en) Galanthamine, or compounds analogous thereto, for treatment of Alzheimer's disease.
DE69129800D1 (en) TREATMENT OF HUMAN RETROVIRUS INFECTIONS WITH 2 ', 3'-DIDEOXYINOSINE
DE69925256D1 (en) TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR THE TREATMENT OF HIV INFECTIONS
DE69825292D1 (en) USE OF INOSINE FOR PRODUCING A MEDICINE FOR STIMULATING AXON GROWTH OF CNS NEURONES
RU94020410A (en) Method of vomiting treatment or prophylaxis in mammalian and human using the certain quinuclidine, piperidine, azanorbornane, ethylenediamine derivatives and related compounds
DE69623899D1 (en) Treatment of tinnitus with neuroprotective agents
FI964771A0 (en) (a) annealed pyrrole derivatives and their use in pharmacin
FR2711140B1 (en) 1-Naphtylpyrazole-3-substituted carboxamides active on neurotensin, their preparation, pharmaceutical compositions containing them.
TR199800801T2 (en) Treatment of traumatic brain injuries.
DE68913739D1 (en) COSMETIC AND SKIN TREATMENT COMPOSITIONS.
DK0604183T3 (en) HIV protease inhibitors useful in the treatment of AIDS
ATE137223T1 (en) LEUCOTRIEN B4 ANTAGONISTS
ATE123024T1 (en) 4-AMINOPYRIDINE DERIVATIVES.
DK0562705T3 (en) Use of L-deprenyl in the manufacture of a drug for the treatment of Cushing's disease
BR9712141A (en) Application of 1-hyphroxy-2-pyridones to treat skin infections.
DK0764632T3 (en) Selective beta3-adrenergic agonists
ATE139440T1 (en) TREATMENT OF INFLAMMATORY BOWEL DISEASE
ATE148109T1 (en) HIV PROTEASE INHIBITORS AND THEIR USE IN THE TREATMENT OF AIDS
TR199802200A2 (en) S �lfonamid s �bstit �e edilmi � benzopiran t �revleri, �retilme y �ntemi.
FR2689017B1 (en) MEDICAL OR VETERINARY INJECTION APPARATUS.
DE69419954D1 (en) Medicines for the treatment of skin diseases
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
DE69334087D1 (en) Drug composition containing TCF-II
BG101145A (en) USE OF / S / -ADENOSYL-L-METHYONINE / ONLY / AND ITS PHYSIOLOGICAL COMPATIBLE SALTS FOR TREATMENT OF NON-PERFUSION INJURY, CAUSED
DE3872425D1 (en) SUBSTITUTED TETRAHYDROISOCHINOLINE COMPOUNDS, THEIR PRODUCTION AND THEIR PHARMACEUTICAL AGENTS CONTAINING THEM.